<- Go Home
Turn Therapeutics Inc.
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Market Cap
$372.1M
Volume
178.0K
Cash and Equivalents
$10.3M
EBITDA
-$8.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$1.6M
Profit Margin
N/A
52 Week High
$26.50
52 Week Low
$2.57
Dividend
N/A
Price / Book Value
541.65
Price / Earnings
-42.77
Price / Tangible Book Value
-1.7K
Enterprise Value
$367.9M
Enterprise Value / EBITDA
-43.25
Operating Income
-$8.6M
Return on Equity
686.28%
Return on Assets
-50.27
Cash and Short Term Investments
$10.3M
Debt
$6.1M
Equity
$686.9K
Revenue
N/A
Unlevered FCF
$4.2M
Sector
Pharmaceuticals
Category
N/A